Risk factor
Poor trading liquidity
Profitability factor
Slightly undervalued vs peers
About
Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products comprising vitamins and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system,...
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, reasonably
Target Price
The average target price of 7148.KL is 1.7 and suggests 29% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell